{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:49:25Z","timestamp":1761580165180},"reference-count":22,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2003.07.021","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T13:16:36Z","timestamp":1068902196000},"page":"2023-2030","source":"Crossref","is-referenced-by-count":32,"title":["Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli"],"prefix":"10.1016","volume":"22","author":[{"given":"Joseli","family":"Oliveira-Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Vargas-Serrato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W","family":"Barnwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R","family":"Galinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2003.07.021_BIB1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/infdis\/164.1.222","article-title":"Chloroquine resistance in Plasmodium vivax","volume":"164","author":"Collignon","year":"1991","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB2","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/0035-9203(94)90305-0","article-title":"High dose of primaquine in primaquine resistant vivax malaria","volume":"88","author":"Bunnag","year":"1994","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB3","unstructured":"Barnwell JW, Galinski MR. Invasion of vertebrate cells: erythrocytes. In: Sherman IW, editor. Malaria: parasite biology, pathogenesis, protection. New York: ASM Press; 1998. p. 93\u2013120."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB4","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1073\/pnas.88.9.4030","article-title":"Primary structure of the merozoite surface antigen 1 of Plasmodium vivax reveals sequences conserved between different Plasmodium species","volume":"88","author":"Del Portillo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-6851(99)00063-8","article-title":"Plasmodium vivax merozoite surface protein-3: coiled-coil motifs within an alanine-rich central domain","volume":"101","author":"Galinski","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0166-6851(01)00458-3","article-title":"The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite","volume":"120","author":"Black","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB7","first-page":"238","article-title":"Plasmodium vivax, P. cynomolgi and P. knowlesi: identification of homologue proteins associated with the surface of merozoites","volume":"91","author":"Barnwell","year":"1999","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-6851(01)00433-9","article-title":"Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101\/ABRA of P. falciparum","volume":"120","author":"Vargas-Serrato","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1128\/IAI.66.4.1500-1506.1998","article-title":"Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria","volume":"66","author":"Perera","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CDLI.8.1.14-20.2001","article-title":"Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea","volume":"8","author":"Park","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.65.5.1606-1614.1997","article-title":"Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria","volume":"65","author":"Soares","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4269\/ajtmh.1994.51.68","article-title":"Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax","volume":"51","author":"Levitus","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4269\/ajtmh.1999.60.350","article-title":"Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys","volume":"60","author":"Collins","year":"1999","journal-title":"Am. J. Trop Med. Hyg."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB14","first-page":"1","article-title":"Phylogenetic analysis of CSP and MSP-9 gene sequences demonstrates the close relationship of Plasmodium coatneyi and Plasmodium knowlesi","volume":"79","author":"Vargas-Serrato","year":"2003","journal-title":"Infect. Gen. E"},{"key":"10.1016\/j.vaccine.2003.07.021_BIB15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0021-9258(18)37973-0","article-title":"Primary structure of Plasmodium falciparum malaria antigen at the merozoite surface and within the parasithophorous vacuole","volume":"263","author":"Weber","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-5890(01)00080-3","article-title":"Plasmodium vivax malaria vaccine development","volume":"38","author":"Arevalo-Herrera","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/341776","article-title":"Age-acquired immunity to a Plasmodium vivax invasion ligand, the Duffy binding protein","volume":"186","author":"Cole-Tobian","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB18","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1128\/IAI.59.10.3547-3554.1991","article-title":"Antimalarial antibodies to immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii","volume":"59","author":"White","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0264-410X(00)00257-7","article-title":"Mycobaterium bovis bacillus calmette-gu\u00e9rin induces protective immunity against infection by Plasmodium yoelii at blood stage depending on shifting immunity toward TH1 type and inducing protective IgG2a after the parasite infection","volume":"19","author":"Matsumoto","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.07.021_BIB20","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/IAI.64.9.3532-3536.1996","article-title":"Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with C-terminus of merozoite surface protein plus novel adjuvant","volume":"64","author":"De Souza","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.07.021_BIB21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0264-410X(99)00326-6","article-title":"Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1","volume":"18","author":"Matsumoto","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.07.021_BIB22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-3024.2001.00390.x","article-title":"Immunogenicity of recombinant fragments of Plasmodium falciparum acid basic repeat antigen produced in Escherichia coli","volume":"23","author":"Kushwaha","year":"2001","journal-title":"Parasite Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0300728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0300728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T23:41:42Z","timestamp":1623541302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0300728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":22,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X0300728X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.07.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}